ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,064Medicare Part D Prescriptions Filled, Including Refills

Rank: 17 out of 55

$248K Total Retail Price of All Prescriptions

Rank: 26 out of 55

213 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 213 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

20% of this provider’s 213 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

2% of this provider’s 4,120 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
POTASSIUM CHLORIDE 311 224 1 7
LEVOTHYROXINE SODIUM 299 243 2 3
FUROSEMIDE 281 175 3 5
LISINOPRIL 253 155 4 2
HYDROCODONE-ACETAMINOPHEN 245 95 S3 5 1
METFORMIN HCL 184 112 6 8
OMEPRAZOLE 177 93 7 4
SIMVASTATIN 168 89 8 6
NAMENDA 168 136 8 23
GABAPENTIN 167 86 10 10
CITALOPRAM HBR 142 74 11 12
TRAMADOL HCL 132 88 12 13
RANITIDINE HCL 115 84 13 29
HYDROCHLOROTHIAZIDE 109 86 14 15
MELOXICAM 107 82 15 11
WARFARIN SODIUM 103 88 16 21
AMLODIPINE BESYLATE 100 87 17 9
CLONIDINE HCL 94 34 18 38
VALPROIC ACID 94 43 18 154
METOPROLOL SUCCINATE 87 65 20 18
FENTANYL 78 20 S2 21 61
CIPROFLOXACIN HCL 78 58 21 32
CARISOPRODOL 76 0 R 23 26
COMBIVENT 76 36 23 163
GLIPIZIDE 71 40 25 101
SERTRALINE HCL 69 23 26 22
CARBIDOPA-LEVODOPA 66 45 27 69
PROMETHAZINE HCL 65 13 R 28 79
LANTUS 60 31 29 37
DONEPEZIL HCL 60 60 29 24
DOXYCYCLINE HYCLATE 59 31 31 98
AZITHROMYCIN 56 35 32 36
FLUTICASONE PROPIONATE 54 21 33 46
LOVASTATIN 51 32 34 89
RISPERIDONE 51 31 34 49
MORPHINE SULFATE ER 51 0 S2 34 41
LOSARTAN POTASSIUM 50 43 37 40
AMOXICILLIN 50 36 37 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.